Esperion Therapeutics shares owned by Bellevue Group
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Bellevue Group
from 13F filings
Historical chart of Bellevue Group investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by Bellevue Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $16M | 9.9M | 1.65 |
| 2024-06-30 | $22M | 9.9M | 2.22 |
| 2024-03-31 | $27M | 9.9M | 2.68 |
| 2023-12-31 | $13M | 4.2M | 2.99 |
| 2023-09-30 | $4.1M | 4.2M | 0.98 |
| 2023-06-30 | $5.8M | 4.2M | 1.39 |
| 2023-03-31 | $6.7M | 4.2M | 1.59 |
| 2022-12-31 | $27M | 4.3M | 6.23 |
| 2022-09-30 | $28M | 4.2M | 6.70 |
| 2022-06-30 | $27M | 4.2M | 6.36 |
| 2022-03-31 | $20M | 4.3M | 4.64 |
| 2021-12-31 | $23M | 4.5M | 5.00 |
| 2021-09-30 | $54M | 4.5M | 12.04 |
| 2021-06-30 | $96M | 4.5M | 21.14 |
| 2021-03-31 | $112M | 4.0M | 28.06 |
| 2020-12-31 | $134M | 5.1M | 26.00 |
| 2020-09-30 | $203M | 5.5M | 37.16 |
| 2020-06-30 | $272M | 5.3M | 51.31 |
| 2020-03-31 | $159M | 5.0M | 31.53 |
| 2019-12-31 | $270M | 4.5M | 59.63 |
| 2019-09-30 | $156M | 4.2M | 36.66 |
| 2019-06-30 | $189M | 4.1M | 46.52 |
| 2019-03-31 | $20M | 496k | 40.15 |
| 2018-12-31 | $21M | 452k | 46.00 |
| 2018-09-30 | $17M | 392k | 44.37 |
| 2018-06-30 | $12M | 314k | 39.19 |
| 2018-03-31 | $13M | 173k | 72.33 |
| 2017-12-31 | $514k | 7.8k | 65.90 |
| 2017-09-30 | $401k | 8.0k | 50.12 |
| 2017-06-30 | $370k | 8.0k | 46.25 |
| 2017-03-31 | $1.1M | 32k | 35.31 |
| 2016-12-31 | $501k | 40k | 12.52 |
| 2016-09-30 | $554k | 40k | 13.85 |
| 2016-06-30 | $395k | 40k | 9.88 |
| 2016-03-31 | $676k | 40k | 16.90 |